Fluconazole in the prevention of infection in neonates

Not Applicable

• Conditions: Condition 1: Candidiasis. Condition 2: Sepsis.; Candidiasis; Other sepsis

• Registration Number: IRCT20170215032587N4
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Neonates with birth weight under 1200 grams
Admitted to neonatal intensive care unite

Exclusion Criteria

Major congenital anomalies

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sepsis. Timepoint: 6 weeks after intervention. Method of measurement: Clinical symptoms and blood culture.

Secondary Outcome Measures

Name	Time	Method
Pneumothorax. Timepoint: 6 weeks after intervention. Method of measurement: Chest X-ray.